Yi Deng and Bill Mezzanotte Elected to University City Science Center Board of Directors
The University City Science Center announces the election of two new Board members, following the 2020 Annual Meeting of Shareholders held on June 19th: Yi Deng, Ph.D., Dean and Isaac L. Auerbach Professor in the College of Computing and Informatics at Drexel University, and Bill Mezzanotte, M.D., M.P.H., Executive Vice President, Head of Research and Development and Chief Medical Officer at CSL Behring.
“I am both honored and excited to join the Board. The Science Center has been a powerhouse to drive and support innovation, research, talent development and entrepreneurship in our city and beyond,” said Dr. Deng. “I look forward to being a part of this exciting and important endeavor.”
Recommended AI News: AiThority Interview With Elie Melois, CTO And Co-Founder At LumApps
At Drexel, Dr. Deng is leading the transformation of CCI into a pacesetter in reshaping computing and informatics education and research in today’s information and technology-driven economy. Under his leadership, CCI has become the fastest growing college at the university, with 35% growth in enrollment in only three years. The college has also launched an array of new initiatives to transform its academic programs, with a focus on research, diversity, industry and international partnerships. Dr. Deng received his PhD in Computer Science from the University of Pittsburgh and a Bachelor of Engineering degree in Computer Science & Technology from the University of Science and Technology of China.
Recommended AI News: Now Live: Udacity Machine Learning Scholarship Program For Microsoft Azure
“The University City Science Center has a hunger for change, curiosity to push beyond the status quo and ability to initiate local partnerships that can turn great ideas into meaningful innovations,” said Dr. Mezzanotte. “I look forward to working with my colleagues on the Science Center Board to continue to advance the impact the life sciences community within the Greater Philadelphia Region has on improving people’s lives around the world.”
Dr. Mezzanotte is responsible for developing and executing CSL Behring’s Research & Development strategy and portfolio, including the identification and development of all R&D platforms, skills and expertise necessary for achieving the company’s patient-focused mission. Dr. Mezzanotte holds an undergraduate degree from Villanova University, obtained his M.D. at the University of Pennsylvania and a Master of Public Health degree from Johns Hopkins University. He is board certified in internal medicine, pulmonary medicine, critical care medicine and sleep medicine.
Recommended AI News: AiThority Interview With Gabe Dalporto, CEO At Udacity